Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide

Article info

Extended reports

Ignacio Martin-Suarez aLupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London , bRoyal Hospitals Trust, London PubMed articles Google scholar articles
David D’Cruz aLupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London , bRoyal Hospitals Trust, London PubMed articles Google scholar articles
Mohammed Mansoor aLupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London , bRoyal Hospitals Trust, London PubMed articles Google scholar articles
Ana Paula Fernandes aLupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London , bRoyal Hospitals Trust, London PubMed articles Google scholar articles
Munther A Khamashta aLupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London , bRoyal Hospitals Trust, London PubMed articles Google scholar articles
Graham R V Hughes aLupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London , bRoyal Hospitals Trust, London PubMed articles Google scholar articles

Dr M A Khamashta, Lupus Arthritis Research Unit, The Rayne Institute, St Thomas’s Hospital, London SE1 7EH.

Citation

Martin-Suarez I, D’Cruz D, Mansoor M, et al

Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide

Annals of the Rheumatic Diseases 1997;56:481-487.

Online issue publication

January 09, 2022

Annals of the Rheumatic Diseases